IP Library Granted Patent US 9,169,354
Granted Patent B2
US 9,169,354 · App. 13/367,128 · Granted Oct 27, 2015

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Inventors: Kunsang Yoon (Madison, AL); J. Milton Harris (Huntsville, AL); Michael David Bentley (Huntsville, AL)
Assignee: Serina Therapeutics, Inc.
C08G73/0233C08G73/028
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,169,354
App. No.
13/367,128
Granted
Oct 27, 2015
Kind
B2
Abstract

The present disclosure provides copolymers of 2-substituted-2-oxazolines possessing two or three reactive functional groups which are also chemically orthogonal. The copolymers described may be random copolymers, block copolymers or a mixture of random and block copolymer configurations. Furthermore, the present disclosure provides novel methods for synthesizing the above polymers and for conjugating to molecules such as targeting, diagnostic and therapeutic agents.

Claims (21)

1. A heterofunctional polyoxazoline derivative of the general structure:

R 1 —{[N(COX)CH 2 CH 2 ] o —[N(COR 2 )CH 2 —CH 2 )] n —[N(COY)CH 2 —CH 2 )] m } a —Z

wherein:

R 1 is an initiating group;

R 2 is independently selected for each repeating unit from an unsubstituted or substituted alkyl, an unsubstituted or substituted alkenyl, an unsubstituted or substituted aralkyl or an unsubstituted or substituted heterocyclylalkyl group;

X is a pendent moiety containing a first functional group;

Y is a pendent moiety containing a second functional group;

Z is a terminating nucleophile, wherein Z is is S—U—W, wherein U is a linking group and W is a third functional group selected from the group consisting of: an alkyne, an amine, an oxyamine, an aldehyde, a ketone, an acetal, a ketal, an ester, a carboxylic acid, an activated carboxylic acid, an active carbonate, a chloroformate, an alcohol, an azide, a vinyl sulfone, a maleimide or orthopyridyl disulfide;

a is ran which indicates a random copolymer or block which indicates a block copolymer;

o and m are each an integer independently selected from 1-50;

n is an integer selected from 0-1000; and

wherein the first and second functional groups are chemically orthogonal to one another.

2. The heterofunctional polyoxazoline derivative of claim 1 wherein R 1 is a hydrogen, substituted or unsubstituted alkyl or substituted or unsubstituted aralkyl group.

3. The heterofunctional polyoxazoline derivative of claim 1 wherein the first and second functional groups are each independently an alkyne, an amine, an oxyamine, an aldehyde, a ketone, an acetal, a ketal, an ester, a carboxylic acid, an activated carboxylic acid, an active carbonate, a chloroformate, an alcohol, an azide, a vinyl sulfone, a maleimide or orthopyridyl disulfide.

4. The heterofunctional polyoxazoline derivative of claim 3 wherein the carboxylic acid is a negatively charged species and the amine is a positively charged species.

5. The heterofunctional polyoxazoline derivative of claim 1 wherein the first and second functional groups are each chemically orthogonal to the third functional group.

6. The heterofunctional polyoxazoline derivative of claim 1 wherein W is an alkyne, an amine, a carboxylic acid, or an activated carboxylic acid.

7. The heterofunctional polyoxazoline derivative of claim 1 wherein W is —CO 2 H or —NH 2 .

8. The heterofunctional polyoxazoline derivative of claim 1 wherein at least one of the first and second functional groups is chemically orthogonal to the third functional group.

9. The heterofunctional polyoxazoline derivative of claim 1 linked to at least one target molecule to form a target molecule-POZ conjugate.

10. The heterofunctional polyoxazoline derivative of claim 9 , where the at least one target molecule is a therapeutic agent, a targeting agent or a therapeutic agent and a targeting agent.

Assignments (1)
CHANGE OF NAME Recorded Apr 9, 2024
From: SERINA THERAPEUTICS, INC.
To: SERINA THERAPEUTICS (AL), INC.
Reel/Frame 067050/0622 →
Continuity (4)
Division 12744472
Provisional Application 61020684 · Jan 11, 2008
Provisional Application 61029337 · Feb 16, 2008
Related Publication 20120136123A1 · May 31, 2012